{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:59Z","timestamp":1791584819365,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300423156"],"award-info":[{"award-number":["252300423156"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["25HASTIT062"],"award-info":[{"award-number":["25HASTIT062"]}],"id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["23HASTIT044"],"award-info":[{"award-number":["23HASTIT044"]}],"id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305087"],"award-info":[{"award-number":["82305087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102311249"],"award-info":[{"award-number":["242102311249"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118383","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:03:44Z","timestamp":1763636624000},"page":"118383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P3","title":["Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy"],"prefix":"10.1016","volume":"302","author":[{"given":"Tiancheng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-3664","authenticated-orcid":false,"given":"Zhonghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jige","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118383_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"issue":"20","key":"10.1016\/j.ejmech.2025.118383_bib4","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer's disease: from immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118383_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jconrel.2024.09.012","article-title":"Amyloid-\u03b2-targeting immunotherapies for alzheimer's disease","volume":"375","author":"Jin","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2025.118383_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.apha.2024.10.005","article-title":"Phosphodiesterase 4 (PDE4) and neurological disorders: a promising frontier in neuropharmacology","volume":"102","author":"Nahid","year":"2025","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13311-014-0309-7","article-title":"Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer's disease","volume":"12","author":"Gurney","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"15","key":"10.1016\/j.ejmech.2025.118383_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158052","article-title":"PDE4D: a multipurpose pharmacological target","volume":"25","author":"Lusardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cellsig.2013.10.007","article-title":"Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain","volume":"26","author":"Kelly","year":"2014","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118383_bib10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2174\/1570159X19666201223154009","article-title":"Recent evidence in epigenomics and proteomics biomarkers for early and minimally invasive diagnosis of alzheimer's and parkinson's diseases","volume":"19","author":"Mayo","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14592","article-title":"Identification of 16 novel Alzheimer's disease loci using multi-ancestry meta-analyses","volume":"21","author":"Willett","year":"2025","journal-title":"Alzheimer's Dement."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118383_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ijnp\/pyaa048","article-title":"The Phosphodiesterase-4 inhibitor roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimer's disease: a preclinical study in APP\/PS1 transgenic mice","volume":"23","author":"Wang","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118383_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152761","article-title":"Baicalein promotes the microglia M2 polarization and suppresses apoptosis by targeting HMOX1\/PDE4D to alleviate Alzheimer's disease","volume":"228","author":"Gong","year":"2023","journal-title":"Immunobiology"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118383_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118383_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2022.12.020","article-title":"Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis","volume":"109","author":"Schepers","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejmech.2025.118383_bib16","article-title":"Comparison of the pharmacological profiles of selective PDE4B and PDE4D inhibitors in the central nervous system","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118383_bib17","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1111\/bph.13257","article-title":"Phosphodiesterase 4D: an enzyme to remember","volume":"172","author":"Ricciarelli","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118383_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2022.12.020","article-title":"Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis","volume":"109","author":"Schepers","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118383_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/1673-5374.380899","article-title":"Novel insights in phosphodiesterase 4 subtype inhibition to target neuroinflammation and stimulate remyelination","volume":"19","author":"Schepers","year":"2024","journal-title":"Neural Regen Res"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118383_bib20","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s10571-023-01349-1","article-title":"Phosphodiesterase-4 inhibition in Parkinson's disease: molecular insights and therapeutic potential","volume":"43","author":"Roy","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118383_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.118383_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105078","article-title":"Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders","volume":"160","author":"Bhat","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118383_bib23","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"issue":"14","key":"10.1016\/j.ejmech.2025.118383_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411518","article-title":"PDE4 inhibitors: profiling hits through the multitude of structural classes","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","article-title":"Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect","volume":"407","author":"Cherry","year":"1999","journal-title":"J. Comp. Neurol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118383_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cellsig.2015.11.001","article-title":"PDE4D phosphorylation: a coincidence detector integrating multiple signaling pathways","volume":"28","author":"Mika","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2025.118383_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115195","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"250","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118383_bib28","article-title":"The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer's disease and Parkinson's disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ajhg.2012.03.004","article-title":"Exome sequencing identifies PDE4D mutations in acrodysostosis","volume":"90","author":"Lee","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmech.2025.118383_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2020.10.004","article-title":"Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer's disease","volume":"97","author":"Paes","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"13","key":"10.1016\/j.ejmech.2025.118383_bib31","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/1873-3468.14902","article-title":"Beta-amyloid interacts with and activates the long-form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability","volume":"598","author":"Sin","year":"2024","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118383_bib33","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/j.1476-5381.2011.01524.x","article-title":"GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses","volume":"164","author":"Bruno","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JAD-122236","article-title":"RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-\u03b242-induced memory deficits in mice","volume":"38","author":"Zhang","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/jpet.119.259986","article-title":"Protection from amyloid \u03b2 peptide-induced memory, biochemical, and morphological deficits by a Phosphodiesterase-4D allosteric inhibitor","volume":"371","author":"Cui","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5093","key":"10.1016\/j.ejmech.2025.118383_bib36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/2141098a0","article-title":"Postnatal neurogenesis in the guinea-pig","volume":"214","author":"Altman","year":"1967","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1073858408324789","article-title":"From neurotransmitters to neurotrophic factors to neurogenesis","volume":"15","author":"Hagg","year":"2009","journal-title":"Neuroscientist"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020286","article-title":"Implication of adult hippocampal neurogenesis in Alzheimer's disease and potential therapeutic approaches","volume":"11","author":"Essa","year":"2022","journal-title":"Cells"},{"issue":"7344","key":"10.1016\/j.ejmech.2025.118383_bib39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature09817","article-title":"Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation","volume":"472","author":"Sahay","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib40","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","article-title":"Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease","volume":"25","author":"Moreno-Jim\u00e9nez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118383_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101636","article-title":"Neurogenesis in aging and age-related neurodegenerative diseases","volume":"78","author":"Culig","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118383_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105406","article-title":"Anti-LINGO-1 antibody ameliorates cognitive impairment, promotes adult hippocampal neurogenesis, and increases the abundance of CB1R-rich CCK-GABAergic interneurons in AD mice","volume":"156","author":"He","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ame2.12212","article-title":"Hippocampal neurogenesis and pro-neurogenic therapies for alzheimer's disease","volume":"5","author":"Zheng","year":"2022","journal-title":"Animal Model Exp Med"},{"issue":"Pt 12","key":"10.1016\/j.ejmech.2025.118383_bib44","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1093\/brain\/awt273","article-title":"Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles","volume":"136","author":"Andrade-Moraes","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118383_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1713","article-title":"Brain-derived neurotrophic factor-induced regulation of RNA metabolism in neuronal development and synaptic plasticity","volume":"13","author":"Costa","year":"2022","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11064-022-03755-1","article-title":"Brain-derived neurotrophic factor: a novel dynamically regulated therapeutic modulator in neurological disorders","volume":"48","author":"Sharma","year":"2023","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118383_bib47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118383_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1460-9568.2008.06349.x","article-title":"Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice","volume":"28","author":"Rutten","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118383_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.722580","article-title":"Phosphodiesterase-4D knockdown in the prefrontal cortex alleviates memory deficits and synaptic failure in mouse model of Alzheimer's disease","volume":"13","author":"Shi","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"7\u20138","key":"10.1016\/j.ejmech.2025.118383_bib51","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-023-01848-y","article-title":"Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues","volume":"28","author":"Kumari","year":"2023","journal-title":"Apoptosis"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118383_bib52","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s11064-021-03418-7","article-title":"Apoptotic pathways and Alzheimer's disease: probing therapeutic potential","volume":"46","author":"Sharma","year":"2021","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib53","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7150\/ijbs.66760","article-title":"Death-associated protein kinase 1 mediates A\u03b242 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118383_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.220","article-title":"Mature neurons: equipped for survival","volume":"4","author":"Kole","year":"2013","journal-title":"Cell Death Dis."},{"issue":"771","key":"10.1016\/j.ejmech.2025.118383_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf5128","article-title":"Inhibition of an Alzheimer's disease-associated form of necroptosis rescues neuronal death in mouse models","volume":"16","author":"Koper","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118383_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076374","article-title":"Involvement of Bcl-2 family proteins in tetraploidization-related senescence","volume":"24","author":"Barriuso","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118383_bib57","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1159\/000488180","article-title":"Phosphodiesterase 4 inhibitor roflumilast protects rat hippocampal neurons from sevoflurane induced injury via modulation of MEK\/ERK signaling pathway","volume":"45","author":"Peng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2025.118383_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114474","article-title":"Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation","volume":"161","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCRESAHA.113.300536","article-title":"Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging","volume":"114","author":"Pillai","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.118383_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.599389","article-title":"A novel PDE4D inhibitor BPN14770 reverses scopolamine-induced cognitive deficits via cAMP\/SIRT1\/Akt\/Bcl-2 pathway","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118383_bib61","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/08923973.2022.2077215","article-title":"Circular RNA from phosphodiesterase 4D can attenuate chondrocyte apoptosis and matrix degradation under OA milieu induced by IL-1\u03b2 via circPDE4D\/miR-4306\/SOX9 Cascade","volume":"44","author":"Gao","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","article-title":"Inflammatory aspects of Alzheimer's disease","volume":"148","author":"Botella Lucena","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118383_bib64","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.118383_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114503","article-title":"Discovery of novel 2,3-dihydro-1H-inden-1-ones as dual PDE4\/AChE inhibitors with more potency against neuroinflammation for the treatment of Alzheimer's disease","volume":"238","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118383_bib66","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2016.08.052","article-title":"Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings","volume":"124","author":"Zhou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/jpet.116.239608","article-title":"Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the cAMP\/PKA\/CREB signaling pathway and NF-\u03baB inhibition","volume":"362","author":"Zou","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118383_bib68","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1080\/07391102.2023.2263586","article-title":"In silico identification of colchicine derivatives as novel and potential inhibitors based on molecular docking and dynamic simulations targeting multifactorial drug targets involved in Alzheimer's disease","volume":"42","author":"Raturi","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118383_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030479","article-title":"Insight into inhibitory mechanism of PDE4D by dietary polyphenols using molecular dynamics simulations and free energy calculations","volume":"11","author":"Furlan","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib70","first-page":"1","article-title":"Roflumilast for the treatment of seborrheic dermatitis: a review","volume":"30","author":"Miller","year":"2025","journal-title":"Skin Therapy Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11011-018-0374-4","article-title":"Roflumilast ameliorates cognitive impairment in APP\/PS1 mice via cAMP\/CREB\/BDNF signaling and anti-neuroinflammatory effects","volume":"34","author":"Feng","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12640-024-00713-3","volume":"42","author":"Hasan","year":"2024","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejmech.2025.118383_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117707","article-title":"Roflumilast and cognition enhancement: a translational perspective","volume":"181","author":"Prickaerts","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-017-0709-1","article-title":"Apremilast: a review in psoriasis and psoriatic arthritis","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40272-024-00668-0","article-title":"Apremilast: first pediatric approval","volume":"27","author":"Blair","year":"2025","journal-title":"Paediatr Drugs"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib76","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s13555-020-00389-5","article-title":"Crisaborole ointment, 2%, for treatment of patients with mild-to-moderate atopic dermatitis: systematic literature review and network meta-analysis","volume":"10","author":"Fahrbach","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118383_bib77","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40257-023-00780-w","article-title":"Once-daily crisaborole ointment, 2%, as a long-term maintenance treatment in patients aged \u2265 3 months with mild-to-moderate atopic dermatitis: a 52-Week clinical study","volume":"24","author":"Eichenfield","year":"2023","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118383_bib78","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/brain\/awac136","article-title":"Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation","volume":"146","author":"Oliveros","year":"2023","journal-title":"Brain"},{"issue":"23","key":"10.1016\/j.ejmech.2025.118383_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238448","article-title":"Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases: an update on preclinical and clinical evidence","volume":"27","author":"Angelopoulou","year":"2022","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.ejmech.2025.118383_bib80","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.lfs.2005.10.026","article-title":"Preferential inhibition of human phosphodiesterase 4 by ibudilast","volume":"78","author":"Huang","year":"2006","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.123.001609","article-title":"Pharmacological profile of difamilast, a novel selective phosphodiesterase 4 inhibitor, for topical treatment of atopic dermatitis","volume":"386","author":"Hiyama","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118383_bib82","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2021.10.027","article-title":"Difamilast ointment in adult patients with atopic dermatitis: a phase 3 randomized, double-blind, vehicle-controlled trial","volume":"86","author":"Saeki","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118383_bib83","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1545968307305521","article-title":"A novel phosphodiesterase type 4 inhibitor, HT-0712, enhances rehabilitation-dependent motor recovery and cortical reorganization after focal cortical ischemia","volume":"21","author":"MacDonald","year":"2007","journal-title":"Neurorehabilitation Neural Repair"},{"issue":"13","key":"10.1016\/j.ejmech.2025.118383_bib84","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/npp.2014.154","article-title":"The PDE4 inhibitor HT-0712 improves hippocampus-dependent memory in aged mice","volume":"39","author":"Peters","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"22","key":"10.1016\/j.ejmech.2025.118383_bib85","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1016\/j.bmcl.2010.09.087","article-title":"Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment","volume":"20","author":"Gallant","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1\u20133","key":"10.1016\/j.ejmech.2025.118383_bib86","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2010.02.036","article-title":"Etazolate improves performance in a foraging and homing task in aged rats","volume":"634","author":"Drott","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118383_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106278","article-title":"Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement","volume":"130","author":"Wei","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.114.214155","article-title":"GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species","volume":"350","author":"Rutter","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118383_bib89","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1021\/jm701635j","article-title":"Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors","volume":"51","author":"Zheng","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118383_bib90","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.01.004","article-title":"FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP\/PS1 transgenic mice via cAMP\/PKA\/CREB signaling and anti-inflammatory effects","volume":"116","author":"Guo","year":"2017","journal-title":"Neuropharmacology"},{"issue":"22","key":"10.1016\/j.ejmech.2025.118383_bib91","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1016\/j.bmc.2015.10.033","article-title":"Catecholic amides as potential selective phosphodiesterase 4D inhibitors: design, synthesis, pharmacological evaluation and structure-activity relationships","volume":"23","author":"Zhou","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118383_bib92","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2019.02.023","article-title":"FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia\/reperfusion injury through activation of the AKT\/GSK3\u03b2\/\u03b2-catenin signaling pathway","volume":"163","author":"Xu","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib93","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/acschemneuro.6b00271","article-title":"Discovery of N-Alkyl catecholamides as selective Phosphodiesterase-4 inhibitors with anti-neuroinflammation potential exhibiting antidepressant-like effects at non-emetic doses","volume":"8","author":"Zhou","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118383_bib94","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejmech.2019.02.026","article-title":"Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect","volume":"168","author":"Tang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118383_bib95","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jmedchem.0c00060","article-title":"Discovery and optimization of \u03b1-Mangostin derivatives as novel PDE4 inhibitors for the treatment of vascular dementia","volume":"63","author":"Liang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118383_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102449","article-title":"Efficacy of selective PDE4D negative allosteric modulators in the object retrieval task in female cynomolgus monkeys (Macaca fascicularis)","volume":"9","author":"Sutcliffe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118383_bib97","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nlm.2017.12.008","article-title":"A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury","volume":"148","author":"Titus","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118383_bib98","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/s41386-018-0178-6","article-title":"Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice","volume":"43","author":"Zhang","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.ejmech.2025.118383_bib99","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/acs.jmedchem.9b00193","article-title":"Design and synthesis of selective phosphodiesterase 4D (PDE4D) allosteric inhibitors for the treatment of fragile X syndrome and other brain disorders","volume":"62","author":"Gurney","year":"2019","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118383_bib100","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41591-021-01321-w","article-title":"Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial","volume":"27","author":"Berry-Kravis","year":"2021","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118383_bib101","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14656566.2024.2323605","article-title":"Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence","volume":"25","author":"Watkins","year":"2024","journal-title":"Expet Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118383_bib102","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s13555-023-01054-3","article-title":"Next generation PDE4 inhibitors that selectively target PDE4B\/D subtypes: a narrative review","volume":"13","author":"Blauvelt","year":"2023","journal-title":"Dermatol. Ther."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118383_bib103","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1021\/jm900977c","article-title":"New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms","volume":"52","author":"Bruno","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118383_bib104","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuropharm.2013.09.015","article-title":"Improvement of spatial memory function in APPswe\/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D","volume":"77","author":"Sierksma","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118383_bib105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejmech.2016.08.018","article-title":"New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment","volume":"124","author":"Brullo","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118383_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/srep46320","article-title":"Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease","volume":"7","author":"Ricciarelli","year":"2017","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118383_bib107","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","article-title":"Design, synthesis, and evaluation of orally available Clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer's disease","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118383_bib108","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acschemneuro.9b00409","article-title":"WBQ5187, a multitarget directed agent, ameliorates cognitive impairment in a transgenic mouse model of Alzheimer's disease and modulates cerebral \u03b2-Amyloid, gliosis, cAMP levels, and neurodegeneration","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118383_bib109","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ejmech.2018.12.013","article-title":"Synthesis and evaluation of clioquinol-rolipram\/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"163","author":"Hu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118383_bib110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0960-894X(01)00720-X","article-title":"Synthesis of 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridine-6-yl)-benzoic acid: a potent and selective phosphodiesterase type 4D inhibitor","volume":"12","author":"Hersperger","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.301.1.241","article-title":"Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities","volume":"301","author":"Trifilieff","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118383_bib112","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/ol403282f","article-title":"New phosphodiesterase-4 inhibitors with an unprecedented skeleton from Selaginella pulvinata","volume":"16","author":"Liu","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.118383_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2017.01.016","article-title":"The discovery, complex crystal structure, and recognition mechanism of a novel natural PDE4 inhibitor from Selaginella pulvinata","volume":"130","author":"Huang","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118383_bib114","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bmcl.2019.06.056","article-title":"Dual functional cholinesterase and PDE4D inhibitors for the treatment of Alzheimer's disease: design, synthesis and evaluation of tacrine-pyrazolo[3,4-b]pyridine hybrids","volume":"29","author":"Pan","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"10","key":"10.1016\/j.ejmech.2025.118383_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162895","article-title":"Synthesis, pharmacological profile and docking studies of new sulfonamides designed as Phosphodiesterase-4 inhibitors","volume":"11","author":"Nunes","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118383_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112492","article-title":"Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: in vitro and in vivo preclinical studies","volume":"204","author":"Nunes","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118383_bib117","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1021\/acs.jmedchem.7b01370","article-title":"Novel phosphodiesterase inhibitors for cognitive improvement in Alzheimer's disease","volume":"61","author":"Wu","year":"2018","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:37:07Z","timestamp":1773819427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":117,"alternative-id":["S0223523425011481"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118383","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118383"}}